ReGen signs first deal for Colostrinin
ReGen Therapeutics is poised for the first launch of its Colostrinin neutraceutical for early stage cognitive decline, with the signing of a licensing agreement with Metagenics in North America.
ReGen Therapeutics is poised for the first launch of its Colostrinin neutraceutical for early stage cognitive decline, with the signing of a licensing agreement with Metagenics in North America.
Ocean Nutrition Canada has brought omega-3 to school lunches in Ontario, teaming up with school supplier Good Foods Enterprises with a cookie containing its proprietary fish oil ingredient MEG-3.
A group of scientists has claimed that Unilever's genetically modified (GM) fish antifreeze protein for ice cream should not be approved without further comprehensive tests.
An increased intake of vegetable protein and cereal fibre could cut the risk of hypertension by up to 50 per cent, says a new study from Spain.
The general trend towards healthier eating has resulted in American consumers turning away from carefree snacks, and opting instead for healthier products, according to Snack Food Trends in the US, a new report by Packaged Facts.
Extracts from blueberries and strawberries could protect against the oxidative stress behind aging, and could even protect astronauts from dangerous galactic radiation, suggests a new study partly supported by NASA.
A new study has shown Pycnogenol to be more effective than a conventional drug in reducing the symptoms of chronic venous insufficiency (CVI), adding to 35 years of research into the benefits of the antioxidant derived from French pine bark.
The FDA has exerted post-market regulatory muscle by testing the contents of several sexual health supplements sold via the Internet in a first-of-its-kind survey and subsequently issued a warning, in which it calls them illegal drugs.